Rare Variant and Epigenomic Analysis in ME/CFS
Duration: 36 months, Funding volume: € 999,169
Personalized risk assessment for embryonal tumor predisposition
Funding volume: € 999,003
Uncovering the Genetic Contribution of Human Endogenous Retroviruses to ME/CFS
Duration: 5 months, Funding volume: € 39,504
Persistent Platelet-Monocyte CrossTalk Underlies Failure to Resolve Inflammation and Symptoms in ME/CFS
Duration: 6 months, Funding volume: € 35,860
Cell-Free DNA Liquid Biopsies for Precision Cardiovascular Medicine
Duration: 48 months, Funding volume: € 999,285
Engineering enhanced microbiome function using synthetic ecology
Duration: 48 months, Funding volume: € 897,156